TBAdb is a manually curated database of T-cell receptor (TCR) and B-cell receptor (BCR) targeting specific antigen or diseases.
The database contains three parts, namely TCR-AB, TCR-GD and BCR. These three parts are aimed at collecting sequences and specificity information of TCRA and TCRB, TCR- gamma and TCR-delta and BCR separately.
Our mission is to present the accurate relationship between TCR/BCR and antigens of diseases in a humanized manner. Therefore, in addition to a broad collection and irregularities correction of articles (early since 1990), many other processes also contribute to the goal:
The detailed information, including disease ICD code, sequencing platform, the method used to identify the specificities and so on, is collected.
The exporting of V/J fragments and CDR3 sequences have been double-checked manually to ensure them stand and correct.
In order to help users to obtain specificities of sequence, the experiments in article are grading as showed in the tutorial document.
The code of V/J fragments are standardized following the IMGT to our best.
The format of CDR3 sequences are ruled with starting with (YX)C in V gene region and ending with W or F(GXG) in the J gene region.
The website provides a series of convenient tools to browse, query, stat and visualize the information. A tutorial document is open to download; it will help you to unitize the database.
1. ICDname: the disease ID of International Classification of Disease (ICD) 10th, which the sequence is correlated to.
2. Disease.name: disease which sequences are special to.
3. Category: the category of the disease.
4. Antigen: the amino acid sequence of antigen.
5. Antigen.sequence: the amino acid sequence of antigen.
6. MHC: the type of leukocyte antigen (MHC) of the sample.
7. Locus: the single chain, such as TRA, TRB, TRD, TRG, IGH, IGK, IGL.
8. CDR3.alpha.aa: the amino acid sequence of complementarity determining region 3 (CDR3) for the TCR sequence alpha chain.
9. CDR3.alpha.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the TCR sequence alpha chain.
10. CDR3.beta.aa: the amino acid sequence of complementarity determining region 3 (CDR3) for the TCR sequence beta chain.
11. CDR3.beta.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the TCR sequence beta chain.
12. CDR3.gamma.aa: the amino acid sequence of complementarity determining region 3 (CDR3) for the TCR sequence gamma chain.
13. CDR3.gamma.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the TCR sequence gamma chain.
14. CDR3.delta.aa: the amino acid sequence of complementarity determining region 3 (CDR3) for the TCR sequence delta chain.
15. CDR3.delta.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the TCR sequence delta chain.
16. CDR3.light.aa: the amino acid sequence of complementarity determining region 3 (CDR3) for the BCR sequence light chain.
17. CDR3.light.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the BCR sequence light chain.
18. CDR3.light.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the BCR sequence light chain.
19. CDR3.heavy.nt: the nucleotide sequence of complementarity determining region 3 (CDR3) for the BCR sequence heavy chain.
20. Species: the specie in which the TCR sequence is found (ig. Human, mice).
21. Valpha: identified V(variable) gene segment locus on alpha chain. The reference genes are derived from IMGT database.
22. Jalpha: the id of identified V(joining) gene segment locus on alpha chain. The reference genes are derived from IMGT database.
23. Vbeta: identified V(variable) gene segment for the sequence. The reference genes are derived from IMGT database.
24. Vbeta: identified V(variable) gene segment locus on beta chain. The reference genes are derived from IMGT database.
25. Dbeta: identified D(diversity) gene segment locus on beta chain. The reference genes are derived from IMGT database.
26. Jbeta: the id of identified V(joining) gene segment locus on beta chain. The reference genes are derived from IMGT database.
27. Seq.platform: the sequencing platform (eg. Sanger, ABI3100, ….).
28. Species: the species of samples.
29. Origin: the tissue from which the sample obtained.
30. Nucleotide.type: DNA or RNA, the material used for sequencing.
31. Cell_subtype: the cell type used for sequencing, CD8+ T cells, CD4+T cells or total T cells.
32. Prepare.method: the method used for librarying.
33. Evaluate.method: the assays are used for identifying the specificity of TCR to the antigen or disease.
34. Case.num: how many samples from patients are studied.
35. Control.type: the control sample used in the study.
36. Control.num: how many samples from control individuals are used in this study.
37. Filteration: the threshold for filting.
38. Journal: the journal on which the article published.
39. Pubmed_id: the id categorized by pubmed.
40. Grade: the reliability of specificity of the TCR sequence.
There are four classes of methods been used to evaluate the specificity between sequences and antigens; These methods graded by their accuracy.
1. Selection of antigen-specific T cells using peptide-MHC multimers. peptide-MHC multimers are useful to identify the antigen-specific directly. If specificity of sequences in an article were evaluated by this method, 4 points will be given.
2. Antigen-specific ex vivo proliferation AND Antigen-specific stimulation ex vivo. They are classical methods, that stimulate cells ex vivo with antigen to proliferate them or just detect the proteins expressed by antigen-specific cells. 5 points.
3. Affinity test. These methods, containing SPR, ITC, MST and so on, are used to quantify the affinity between TCR/BCR and antigen. 4 points.
4. Laser microdissection. V/J specific antibodies are used to stain each type V and/or J motifs, then Laser microdissection is employed to detect them on tissue or cells. 1 point..
5. Statistical analysis. Actually, high frequency sequences or public clones are often considered as disease-specific clones. 2 points..
6. If more than two methods are employed, the points will be added up.
TBAdb: a manually curated database of T-cell receptor (TCR) and B-cell receptor (BCR) targeting specific antigen or diseases
Copyright 2016-2019 TBAdb Developers
Attribution-NoDerivatives 4.0 International
Creative Commons Corporation (“Creative Commons”) is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an “as-is” basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.
Using Creative Commons Public Licenses
Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.
Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC-licensed material, or material used under an exception or limitation to copyright. More considerations for licensors.
Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor’s permission is not necessary for any reason–for example, because of any applicable exception or limitation to copyright–then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public.
Creative Commons Attribution-NoDerivatives 4.0
By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NoDerivatives 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.
Section 1 – Definitions.
1. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
2. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
3. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
4. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
5. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
6. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
7. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
8. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
9. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
10. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.
Section 2 – Scope.
1. License grant.
1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
1. reproduce and Share the Licensed Material, in whole or in part; and
2. produce and reproduce, but not Share, Adapted Material.
2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
3. Term. The term of this Public License is specified in Section 6(a).
4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
5. Downstream recipients.
1. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
2. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).
2. Other rights.
1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
2. Patent and trademark rights are not licensed under this Public License.
3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.
Section 3 – License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
1. If You Share the Licensed Material, You must:
1. retain the following if it is supplied by the Licensor with the Licensed Material:
1. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
2. a copyright notice;
3. a notice that refers to this Public License;
4. a notice that refers to the disclaimer of warranties;
5. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
2. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
3. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material.
2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
Section 4 – Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
1. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database, provided You do not Share Adapted Material;
2. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
3. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.
Section 5 – Disclaimer of Warranties and Limitation of Liability.
1. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
2. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
Section 6 – Term and Termination.
1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
2. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:
1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
2. upon express reinstatement by the Licensor.
For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
3. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
4. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.
Section 7 – Other Terms and Conditions.
1. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
2. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.
Section 8 – Interpretation.
1. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
2. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
3. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
4. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.
Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark “Creative Commons” or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.
Creative Commons may be contacted at creativecommons.org.